These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 24025987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.
    Matsunaga N, Suzuki K, Nakanishi T, Ogawa M, Imawaka H, Tamai I.
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):142-8. PubMed ID: 25989889
    [Abstract] [Full Text] [Related]

  • 3. Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
    Matsunaga N, Wada S, Nakanishi T, Ikenaga M, Ogawa M, Tamai I.
    Mol Pharm; 2014 Feb 03; 11(2):568-79. PubMed ID: 24320552
    [Abstract] [Full Text] [Related]

  • 4. Species differences in sinusoidal and canalicular efflux transport of mycophenolic acid 7-O-glucuronide in sandwich-cultured hepatocytes.
    Tetsuka K, Gerst N, Tamura K, Masters JN.
    Pharmacol Res Perspect; 2014 Apr 03; 2(2):e00035. PubMed ID: 25505584
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.
    Kobayashi M, Saitoh H, Kobayashi M, Tadano K, Takahashi Y, Hirano T.
    J Pharmacol Exp Ther; 2004 Jun 03; 309(3):1029-35. PubMed ID: 14978191
    [Abstract] [Full Text] [Related]

  • 6. Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite.
    Dostalek M, Court MH, Hazarika S, Akhlaghi F.
    Drug Metab Dispos; 2011 Mar 03; 39(3):448-55. PubMed ID: 21123165
    [Abstract] [Full Text] [Related]

  • 7. Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats.
    Kwon MH, Yoon JN, Baek YJ, Kim YC, Cho YY, Kang HE.
    Biopharm Drug Dispos; 2016 Sep 03; 37(6):352-65. PubMed ID: 27241939
    [Abstract] [Full Text] [Related]

  • 8. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.
    El-Sheikh AA, Koenderink JB, Wouterse AC, van den Broek PH, Verweij VG, Masereeuw R, Russel FG.
    Transl Res; 2014 Jul 03; 164(1):46-56. PubMed ID: 24486136
    [Abstract] [Full Text] [Related]

  • 9. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
    Djebli N, Picard N, Rérolle JP, Le Meur Y, Marquet P.
    Pharmacogenet Genomics; 2007 May 03; 17(5):321-30. PubMed ID: 17429314
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun 03; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
    Shipkova M, Schütz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E.
    Clin Chem; 2000 Mar 03; 46(3):365-72. PubMed ID: 10702523
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M, Armstrong VW, Weber L, Niedmann PD, Wieland E, Haley J, Tönshoff B, Oellerich M, German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
    Ther Drug Monit; 2002 Jun 03; 24(3):390-9. PubMed ID: 12021631
    [Abstract] [Full Text] [Related]

  • 15. Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.
    Saitoh H, Kobayashi M, Oda M, Nakasato K, Kobayashi M, Tadano K.
    Drug Metab Pharmacokinet; 2006 Oct 03; 21(5):406-13. PubMed ID: 17072094
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
    Mino Y, Naito T, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J.
    Clin Biochem; 2009 May 03; 42(7-8):595-601. PubMed ID: 19100248
    [Abstract] [Full Text] [Related]

  • 18. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T, Mino Y, Otsuka A, Ushiyama T, Ito T, Ozono S, Kagawa Y, Kawakami J.
    J Clin Pharmacol; 2009 Jun 03; 49(6):710-8. PubMed ID: 19451405
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.